|  | original article | Date | Title | Authors   All Authors | 
      | 1 | [GO] | 2024―Apr―22 | New Drug: Andusomeran and raxtozinameran for prevention of COVID-19 disease |  | 
      | 2 | [GO] | 2023―Oct―22 | New Drug: Tozinameran+riltozinameran and tozinameran+famtozinameran for prevention of COVID-19 |  | 
      | 3 | [GO] | 2023―Oct―22 | New Drug: Elasomeran+davesomeran for prevention of COVID-19 |  | 
      | 4 | [GO] | 2023―Oct―22 | COVID-19 vaccines in 2023 | Ketaki Sharma, Jean Li-Kim-Moy | 
      | 5 | [GO] | 2023―Jun―21 | Diagnostic Tests: Testing for COVID-19: a 2023 update | Ella M Meumann, Jennifer MB Robson | 
      | 6 | [GO] | 2022―Oct―12 | New drug: Elasomeran/imelasomeran for prevention of COVID-19 |  | 
      | 7 | [GO] | 2022―Aug―31 | New drug: Tixagevimab and cilgavimab for COVID-19 prophylaxis |  | 
      | 8 | [GO] | 2022―Mar―23 | Editorial: Oral antivirals for mild-moderate COVID-19: a panacea or a logistical and clinical conundrum? | Ian D Coombes, Amy Legg, Tina Petterson, Tanya Kelly, Andrew Henderson, Jason A Roberts | 
      | 9 | [GO] | 2022―Feb―26 | New drug: Nirmatrelvir and ritonavir for COVID-19 |  | 
      | 10 | [GO] | 2022―Feb―26 | New drug: Molnupiravir for COVID-19 |  | 
      | 11 | [GO] | 2022―Feb―26 | New drug: Casirivimab and imdevimab for COVID-19 |  | 
      | 12 | [GO] | 2022―Feb―26 | New drug: SARS-CoV-2 rS (NVX-CoV-2373) vaccine for prevention of COVID-19 |  | 
      | 13 | [GO] | 2021―Sep―28 | New drug: Sotrovimab for COVID-19 |  | 
      | 14 | [GO] | 2021―Sep―06 | New drug: Elasomeran for prevention of COVID-19 |  | 
      | 15 | [GO] | 2021―Mar―09 | New drug: ChAdOx1-S vaccine for prevention of COVID-19 |  | 
      | 16 | [GO] | 2021―Feb―26 | Letter to the Editor: Evolving evidence for immunosuppressants in COVID-19 | Ajay K Shukla, Senthuran Shivakumar, Olivia C Smibert, Jason A Trubiano, Albert G Frauman, David FL Lliew | 
      | 17 | [GO] | 2021―Feb―25 | New drug: BNT162b2 vaccine for prevention of COVID-19 |  | 
      | 18 | [GO] | 2020―Dec―16 | COVID-19 vaccines - are we there yet? | Peter McIntyre, Ye Jin Joo, Clayton Chiu, Katie Flanagan, Kristine Macartney | 
      | 19 | [GO] | 2020―Oct―14 | Diagnostic Tests: Testing for COVID-19 |  | 
      | 20 | [GO] | 2020―Aug―18 | New Drug: Remdesivir for COVID-19 |  | 
      | 21 | [GO] | 2020―Aug―18 | Management of autoimmune disease during the COVID-19 pandemic | Philip C Robinson, Evan C Bursle | 
      | 22 | [GO] | 2020―Jul―31 | Letter to the Editor: QUM and COVID-19 in young adults | Manjiri Gharat, Darren M Roberts, Alexandra Bennett | 
      | 23 | [GO] | 2020―Jun―16 | Editorial: Immunosuppression for COVID-19: repurposing medicines in a pandemic | Senthuran Shivakumar, Olivia C Smibert, Jason A Trubiano, Albert G Frauman, David FL Liew | 
      | 24 | [GO] | 2020―May―07 | Editorial: COVID-19 and the quality use of medicines: evidence, risks and fads | Darren M Roberts, Alexandra Bennett | 
      | 25 | [GO] | 2020―Apr―21 | Editorial: Principles of ethial prescribing for self and others: hydroxychloroquine in the COVID-19 pandemic | Ian Coombes, Alexandra Markwell, Paul Kubler, Andrew M Redmond, Gordon McGurk, Jason A Roberts |